Skip to content

Clinical trials

Diabetic Neuropathies trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20071
20091
20102
20131
20171
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center4
Eli Lilly and Company2
Chromaderm, Inc.1
GlaxoSmithKline1
MEDA Pharma GmbH & Co. KG1
Neurecon BV1
Pfizer1
Tris Pharma, Inc.1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies13
Diabetes Mellitus3
Diabetes Mellitus, Type 22
Anxiety Disorders1
Chronic Pain1
Diabetes Mellitus, Type 11
Diabetic Foot1
Diabetic Nephropathies1
Diabetic Retinopathy1
Pain1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.